Codes / ICD10CM / T50.A93D

T50.A93D Poisoning by other bacterial vaccines, assault, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by other bacterial vaccines, assault, subsequent encounter

Summary

This condition describes harmful effects resulting from exposure to bacterial vaccines not classified under other specific subcategories, occurring as a result of assault, with this encounter being a subsequent one. The clinical presentation and management depend on the specific vaccine involved, the nature of the assault, and the patient's immune response. Subsequent encounters indicate ongoing care for the condition.

Causes

Exposure to other bacterial vaccines in the context of assault may result from forced ingestion, injection, or other deliberate exposure by another individual. The cause is directly associated with the assault event, and adverse effects can arise from the vaccine's components or the patient's immune response to the exposure.

Risk Factors

  • History of allergic reactions to vaccine components (e.g., preservatives, adjuvants)
  • Concurrent use of immunosuppressive medications
  • Underlying immune disorders or compromised immunity
  • Prior adverse reactions to bacterial vaccines
  • Inadequate storage or handling of vaccine products

Symptoms

  • Local reactions (e.g., swelling, redness, pain at exposure site)
  • Systemic symptoms (e.g., fever, chills, malaise)
  • Allergic responses (e.g., rash, urticaria, anaphylaxis)
  • Neurological symptoms (e.g., dizziness, confusion)
  • Gastrointestinal disturbances

Diagnosis

Diagnosis involves confirming exposure to a bacterial vaccine, identifying the assault as the cause, and assessing the patient's clinical presentation. Laboratory tests may evaluate immune response or detect vaccine components. Documentation of the assault and subsequent encounter is critical for accurate coding and care planning.

Treatment Options

Treatment focuses on managing symptoms, addressing adverse reactions, and providing supportive care. This may include antihistamines for allergic responses, corticosteroids for severe reactions, and monitoring for complications. Specific interventions depend on the vaccine involved and the patient's condition.

Prognosis and Follow-Up

Prognosis varies based on the vaccine, severity of exposure, and patient response. Subsequent encounters require ongoing monitoring for delayed reactions or complications. Follow-up care ensures resolution of symptoms and addresses any long-term effects.

Complications

Potential complications include severe allergic reactions (e.g., anaphylaxis), systemic infections, or organ damage from vaccine components. Delayed immune responses or chronic effects may also occur, necessitating extended care.

Lifestyle & Prevention

Prevention involves ensuring secure storage and handling of bacterial vaccines to prevent misuse. For patients, avoiding exposure to unknown or unadministered vaccines and reporting suspicious incidents is important. Supportive measures may include counseling for assault-related trauma.

When to Seek Professional Help

Seek immediate medical attention if symptoms worsen, such as difficulty breathing, severe swelling, or signs of anaphylaxis. Ongoing care is necessary for subsequent encounters to monitor for complications or delayed reactions.

Tips for Medical Coders

Use this code for subsequent encounters related to poisoning by other bacterial vaccines due to assault. Ensure documentation specifies the assault as the cause and confirms the encounter is subsequent. Verify the vaccine type and clinical details to support accurate coding.

Book a walkthrough

T50.A93D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.